Literature DB >> 26195118

[Lung function in patients with diabetes mellitus].

C Fontaine-Delaruelle1, C Viart-Ferber2, C Luyton3, S Couraud4.   

Abstract

INTRODUCTION: Diabetes mellitus is a disease affecting a lot of organs. One of the little known diabetes complication is impairment of pulmonary function. The aim of this study was to compare pulmonary function in two groups: diabetic individuals and obese non-diabetic individuals and to investigate predictive factors of alteration of diffusing capacity of lung for carbon monoxide (DLCO). PATIENTS AND
METHOD: We retrospectively included all patients hospitalized in department of endocrinology between 1st July 2013 and 31 December 2013 and who underwent pulmonary function tests. All these medical charts of patients were reviewed and patients were classified in two groups: diabetic and obese non-diabetic individuals.
RESULTS: Overall, 89 patients were included, 62 diabetic patients and 27 obese non-diabetic patients. Forced vital capacity (FVC), forced expiratory volume in 1 second (FEV1), medium expiratory flow, expiratory residual volume, total lung capacity (TLC) and DLCO were significantly lower in patients with diabetes mellitus compared to obese non-diabetic patients. A low DLCO was significantly associated with diabetic neuropathy, macrovascular complication (carotid atheroma), impairment of renal function, and insulin treatment.
CONCLUSION: Respiratory function is impaired in diabetes mellitus, with a significant decrease in FVC, FEV1, TLC and DLCO.
Copyright © 2015 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Alveolar diffusion capacity; Capacité de diffusion alvéolaire; Diabetes mellitus; Diabète; Exploration fonctionnelle respiratoire; Fonction respiratoire; Lung function; Pulmonary function test

Mesh:

Substances:

Year:  2015        PMID: 26195118     DOI: 10.1016/j.pneumo.2015.03.010

Source DB:  PubMed          Journal:  Rev Pneumol Clin        ISSN: 0761-8417


  5 in total

1.  Transfer factor for carbon monoxide in patients with COPD and diabetes: results from the German COSYCONET cohort.

Authors:  Kathrin Kahnert; Tanja Lucke; Frank Biertz; Andreas Lechner; Henrik Watz; Peter Alter; Robert Bals; Jürgen Behr; Rolf Holle; Rudolf M Huber; Stefan Karrasch; Beate Stubbe; Margarethe Wacker; Sandra Söhler; Emiel F M Wouters; Claus Vogelmeier; Rudolf A Jörres
Journal:  Respir Res       Date:  2017-01-13

Review 2.  Potential Biochemical Mechanisms of Lung Injury in Diabetes.

Authors:  Hong Zheng; Jinzi Wu; Zhen Jin; Liang-Jun Yan
Journal:  Aging Dis       Date:  2017-02-01       Impact factor: 6.745

Review 3.  What is the impact of microvascular complications of diabetes on severe COVID-19?

Authors:  Ruman Basra; Martin Whyte; Janaka Karalliedde; Prashanth Vas
Journal:  Microvasc Res       Date:  2021-12-31       Impact factor: 3.750

4.  Type II diabetes accentuates diaphragm blood flow increases during submaximal exercise in the rat.

Authors:  Alec L E Butenas; Joshua R Smith; Steven W Copp; K Sue Hageman; David C Poole; Timothy I Musch
Journal:  Respir Physiol Neurobiol       Date:  2020-08-07       Impact factor: 1.931

Review 5.  Diabetes and Lung Disease: A Neglected Relationship.

Authors:  Jasmin Khateeb; Eyal Fuchs; Mogher Khamaisi
Journal:  Rev Diabet Stud       Date:  2019-02-25
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.